Orlistat Price Trend and Forecast 2026-2027

Germany held the highest Orlistat price among the tracked markets, easing just above 2.9% in Q2 2026 to near USD 335.00/KG from about USD 345.00/KG in Q1, and it was generic manufacturing capacity expansion together with competitive pressure from newer obesity treatments that defined the market. The global average eased from close to USD 315.00/KG down to about USD 305.00/KG over the same quarter, a decline of just above 3.2%. Notably, this lipase inhibitor can be generically manufactured at very low cost per treatment course, reflecting how mature and price-competitive this API market has become as demand shifts toward newer weight-management drug classes, and the global average is likely to run in the USD 290 to 330/KG range through the second half of the year.

Orlistat is a lipase inhibitor prescribed for weight management and obesity-related comorbidities, working in the intestines to block the absorption of dietary fats by inhibiting pancreatic lipase, an enzyme needed to break down triglycerides. It is used in conjunction with a low-calorie diet and can significantly reduce weight and improve cardiovascular risk factors when combined with a complete weight management program. Approved under brand names including Xenical as a prescription therapy and Alli as an over-the-counter option, the drug has faced growing competitive pressure as the obesity treatment landscape has shifted toward newer injectable drug classes. Because this is a mature, off-patent generic API, generic manufacturing capacity expansion, competitive pressure from newer obesity treatment classes, and regulatory and reimbursement policy affecting market access are what really move the price from quarter to quarter.

Orlistat Price Forecast for 2026

Generic manufacturing capacity continues expanding across every market tracked, which points toward continued gradual price erosion through H2 2026. The broader shift toward newer obesity treatment classes should keep limiting demand growth for this older oral therapy regardless of its established safety profile and lower cost.

A resurgence in demand tied to cost-conscious prescribing or expanded over-the-counter access could be what keeps prices closer to the upper end of this forecast. Continued generic capacity growth, or further market share loss to newer treatment classes, could be what pushes prices below it instead.

For the Quarter Ending June 2026

Orlistat Prices Q2 2026:

• Germany: USD 335.00/KG
• United States: USD 315.00/KG
• China: USD 295.00/KG
• India: USD 275.00/KG

Orlistat Prices in Germany

Germany stayed the priciest market tracked, though the price eased from about USD 345.00/KG to near USD 335.00/KG, a decline of just above 2.9%. It was continued generic manufacturing capacity expansion, together with competitive pressure from newer obesity treatment classes, that gave the market room to ease further.

Why did the price of Orlistat change in Q2 2026 in Germany?

The obesity treatment landscape has shifted markedly toward newer drug classes in recent years, and it is this competitive pressure, combined with generic manufacturing capacity that has continued expanding for this mature, off-patent lipase inhibitor, that has kept German pricing on a steady downward path.

Orlistat Prices in United States

The United States price eased from about USD 325.00/KG to near USD 315.00/KG, a decline of just above 3.1%. It was continued generic price erosion, together with steady but not growing demand amid the broader shift toward newer obesity treatments, that gave the market room to ease.

Why did the price of Orlistat change in Q2 2026 in United States?

The global weight-loss market has increasingly concentrated around newer prescription drug classes, and this shift has left older oral therapies like this lipase inhibitor facing a smaller, more price-competitive niche, and it is this dynamic, combined with continued generic manufacturing capacity, that has kept United States pricing on a gradual downward path.

Orlistat Prices in China

The Chinese price eased from about USD 305.00/KG to near USD 295.00/KG, a decline of just above 3.3%. It was continued generic manufacturing capacity, together with steady but not growing export demand, that gave the market room to ease.

Why did the price of Orlistat change in Q2 2026 in China?

China's substantial generic manufacturing base has continued expanding capacity for this mature API, and it is this expanding supply, combined with export demand that has stayed steady rather than growing amid the broader shift toward newer obesity treatments, that has kept Chinese pricing on its gradual downward path.

Orlistat Prices in India

The Indian price eased from about USD 285.00/KG to near USD 275.00/KG, a decline of just above 3.5%. It was continued generic manufacturing capacity expansion, together with steady export demand, that gave the market room to ease further.

Why did the price of Orlistat change in Q2 2026 in India?

India's substantial bulk API manufacturing base has continued expanding capacity for this mature generic product, and it is this growing supply, combined with export demand that has stayed steady rather than accelerating, that has kept Indian pricing the most affordable of the four markets tracked, on a continued downward path.

For the Quarter Ending March 2026

Orlistat Prices Q1 2026:

• Germany: USD 345.00/KG
• United States: USD 325.00/KG
• China: USD 305.00/KG
• India: USD 285.00/KG

Orlistat Prices in Germany

The price eased to close to USD 345.00/KG in Q1 2026, a decline of just above 4.2% from Q4 2025. It was continued generic price erosion, together with competitive pressure from newer weight-management therapies, that pressured the market lower.

Why did the price of Orlistat change in Q1 2026 in Germany?

This lipase inhibitor can be generically manufactured at very low cost per treatment course, reflecting a mature, highly competitive generic market, and it was continued capacity expansion among generic producers, meeting demand that has shifted toward newer obesity treatment classes, that drove the German decline.

Orlistat Prices in United States

The price eased to close to USD 325.00/KG in Q1 2026, a decline of just above 4.4% from Q4 2025. It was continued generic manufacturing capacity, together with competitive pressure from newer therapies, that pressured the market lower.

Why did the price of Orlistat change in Q1 2026 in United States?

Generic manufacturing capacity continued expanding entering the year, and it was this capacity growth, meeting demand that has shifted toward newer obesity treatment classes, that drove the United States decline.

Orlistat Prices in China

The price eased to close to USD 305.00/KG in Q1 2026, a decline of just above 4.7% from Q4 2025. It was continued generic price erosion that pressured the market lower.

Why did the price of Orlistat change in Q1 2026 in China?

Generic price erosion continued this quarter, and it was expanding domestic manufacturing capacity, meeting export demand that held steady rather than growing, that drove the Chinese decline.

Orlistat Prices in India

The price eased to close to USD 285.00/KG in Q1 2026, a decline of just above 5.0% from Q4 2025. It was continued generic price erosion that pressured the market lower.

Why did the price of Orlistat change in Q1 2026 in India?

Generic price erosion continued this quarter, and it was expanding bulk API manufacturing capacity, meeting export demand that held steady, that drove the Indian decline.

Quarterly Orlistat Price Trends

This market eased in every single quarter over the six tracked here. Close to USD 367.00/KG in Q1 2025 slid to about USD 352.00/KG, near USD 338.00/KG, and close to USD 330.00/KG by Q4, before continuing lower to about USD 315.00/KG in Q1 2026 and near USD 305.00/KG in Q2. That is a decline of roughly 16.9% across the window, tracking the ongoing generic erosion trend closely.

What was Orlistat Price in 2025?

It was expanding generic manufacturing capacity, meeting a mature market facing competitive pressure from newer obesity treatment classes, that drove the consistent 2025 decline. The global average opened near USD 367.00/KG in Q1 and eased to close to USD 330.00/KG by Q4, a decline of just above 10.1% for the year, with every quarter posting a decline.

Orlistat Prices in Germany in 2025

The German price eased from about USD 400.00/KG in Q1 2025 to near USD 360.00/KG by Q4, a decline of just above 10.0% for the year, holding the highest absolute cost among the four markets tracked throughout. It was continued generic manufacturing capacity expansion, meeting a shifting obesity treatment landscape favoring newer drug classes, that drove the sustained decline through 2025.

Orlistat Prices in United States in 2025

The United States price eased from about USD 378.00/KG in Q1 2025 to near USD 340.00/KG by Q4, a decline of just above 10.1% for the year. It was continued generic manufacturing capacity expansion, meeting a mature market facing competitive pressure from newer weight-management drug classes, that drove the sustained decline through 2025.

Orlistat Prices in China in 2025

The Chinese price eased from about USD 355.00/KG in Q1 2025 to near USD 320.00/KG by Q4, a decline of just above 9.9% for the year. It was expanding generic manufacturing capacity, meeting export demand that stayed steady amid the broader shift toward newer obesity treatment classes, that drove the sustained decline through 2025.

Orlistat Prices in India in 2025

The Indian price eased from about USD 335.00/KG in Q1 2025 to near USD 300.00/KG by Q4, a decline of just above 10.4% for the year, the smallest absolute cost among the four markets tracked throughout. It was expanding bulk API manufacturing capacity, combined with India's substantial generic production base, that kept the Indian benchmark the most affordable of the four all year.

How We Can Help

Expert Market Research: Your Source for Real-Time Orlistat Price Intelligence

The Orlistat market has entered a mature, price-competitive phase as generic manufacturing capacity expands and the broader obesity treatment landscape shifts toward newer drug classes, so Expert Market Research tracks generic capacity growth closely alongside competitive dynamics with newer treatment classes and regulatory and reimbursement policy across the four markets covered here. This is combined with trade flow data to build the forecasts. Should the Orlistat pricing data or procurement strategy support be needed, the team is ready to help.